Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Allied BiotechROCO:1780 -1.76%77 OCF Margin % is 40.05% as of Dec. 2025, which is 100% above its 10-year median of 19.98. GuruFocus rates ROCO:1780 with a GF Score™ of 77/100 and a GF Value™ of NT$20.77 (Fairly Valued). The stock has 5 warning signs investors should review. Among 962 Drug Manufacturers companies, Allied Biotech ranks better than 87.63% on this metric.
The historical rank and industry rank for Allied Biotech's OCF Margin % or its related term are showing as below:
ROCO:1780'
s OCF Margin % Range Over the Past 10 Years
Min: 9.62 Med: 19.98 Max: 27.73
Current: 25.56
During the past 13 years, the highest OCF Margin % of Allied Biotech was 27.73%. The lowest was 9.62%. And the median was 19.98%.
ROCO:1780's OCF Margin % is ranked better than 87.63% of 962
companies
in the Drug Manufacturers industry
Industry Median: 10.035
vs ROCO:1780: 25.56
Allied Biotech OCF Margin % Related Terms
Allied Biotech OCF Margin % Historical Data
* Premium members only.
The historical data trend for Allied Biotech's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Allied Biotech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allied Biotech OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Allied Biotech's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Allied Biotech's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allied Biotech (ROCO:1780) has a OCF Margin % of 40.05% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Allied Biotech and its competitors. This is 100% above median its historical median of 19.98. Over the past decade, Allied Biotech's OCF Margin % has ranged from 9.62 to 27.73. According to the industry distribution chart, Allied Biotech ranks #119 out of 962 companies in the Drug Manufacturers industry, placing it in the top 12.4%.
Is Allied Biotech's OCF Margin % too high?
Allied Biotech's current OCF Margin % of 40.05% is 100% above median its 10-year median of 19.98. Over the past 10 years, this metric has ranged from a low of 9.62 to a high of 27.73. The Drug Manufacturers industry median OCF Margin % is 10.04. Allied Biotech's value of 40.05% is 299.1% above this industry median. Based on the distribution chart, Allied Biotech ranks #119 out of 962 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Allied Biotech has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Allied Biotech's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Allied Biotech ranks #119 out of 962 companies for OCF Margin %. This places Allied Biotech in the top 12% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 10.04. Allied Biotech's value of 40.05% is 299.1% above this benchmark. Historically, Allied Biotech's own OCF Margin % has ranged from 9.62 to 27.73 over the past decade. While the company's 10-year median is 19.98 vs. the industry median of 10.04, Allied Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Allied Biotech's current OCF Margin % of 40.05% is 299.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Allied Biotech and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allied Biotech's current OCF Margin % is 40.05%, which is 100% above median its own 10-year median of 19.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allied Biotech stock overvalued right now?
Based on GuruFocus' analysis, Allied Biotech (ROCO:1780) is currently considered Fairly Valued. The stock's GF Value™ is NT$20.77, compared to a current price of NT$22.30 — trading 7.4% above its estimated fair value. The current OCF Margin % is 40.05%, which is 100% above median its 10-year median of 19.98 and 299.1% above the Drug Manufacturers industry median of 10.04. Allied Biotech's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Allied Biotech (ROCO:1780), the current OCF Margin % is 40.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Allied Biotech (ROCO:1780) Overvalued in 2026?
Based on GuruFocus' analysis, Allied Biotech stock appears to be overvalued.
The current stock price of NT$22.30 is trading 7.4% above its estimated GF Value™ of NT$20.77.
GuruFocus considers Allied Biotech to be Fairly Valued.
Key valuation signals for ROCO:1780:
OCF Margin %: 40.05% (100% above median its 10-year median of 19.98)
GF Value™: NT$20.77 vs. price of NT$22.30 (7.4% above fair value)
Industry Position: 299.1% above the Drug Manufacturers median (#119 of 962)
No single metric tells the full story. See the ROCO:1780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.
77GF Score
Get the complete analysis for ROCO:1780
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1780 has been successfully added to your 
